Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes (NCT05294653) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes
China300 participantsStarted 2022-06-01
Plain-language summary
For children and adolescents with diabetes, the pathological process of atherosclerotic cardiovascular disease(ASCVD) can exist in early childhood and progress rapidly to subclinical ASCVD. This study intends to explore the models for the prediction of ASCVD risk in childhood and teen-age onset diabetes with different types.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Diagnosis of type 1 diabetes or type 2 diabetes
. Age of onset: \<18y
. Enrollment age: ≥18y
. Gender: male or female
. Diabetes duration ≥ 5 years
Exclusion criteria
. Specific types of diabetes
. Clinical diagnosis of diabetes is unknown, and it belongs to untyped diabetes
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Occurrence of Atherosclerotic Cardiovascular Disease(ASCVD) high risk rating
Timeframe: 5 years
Trial details
NCT IDNCT05294653
SponsorShanghai Jiao Tong University School of Medicine
. Received glucocorticoids, immunosuppressants, non-glycemic biological agents, and cytotoxic drugs in the past 3 months; non-steroidal pain relievers or antibiotics used for more than 1 week continuously
. Onset of acute complications of diabetes in the past 3 months
. Major trauma and surgery history in the past 3 months